RECURRENT BULLOUS ERYTHEMA MULTIFORME SECONDARY TO HERPES SIMPLEX INFECTION IN AN 18-YEAR-OLD MALE: A CASE STUDY.: BULLOUS ERYTHEMA MULTIFORME

Abraham Mukalazi; Julian  Tumuhairwe Katungi

doi:10.51168/sjhrafrica.v6i3.1570

Authors

Abraham Mukalazi MBChB Dermatology Department, Mbarara University of Science and Technology P.O.BOX 1410 Mbarara, Uganda
KATUNGI MBChB Dermatology Department, Mbarara University of Science and Technology P.O.BOX 1410 Mbarara, Uganda

DOI:

https://doi.org/10.51168/sjhrafrica.v6i3.1570

Keywords:

Bullous erythema multiforme, Recurrent erythema multiforme, Herpes simplex virus, Herpes Simplex Virus-associated erythema multiforme, Acyclovir suppression therapy

Abstract

Introduction

Erythema multiforme (EM) is an acute, immune-mediated mucocutaneous disorder characterized by characteristic targetoid lesions. The bullous subtype is rare and often triggered by infections such as herpes simplex Virus (HSV). Recurrent EM is strongly associated with HSV reactivation.

Case Presentation

We report an 18-year-old HIV-seronegative male with recurrent bullous erythema multiforme secondary to oral HSV infection. The patient had a two-year history of recurrent blistering episodes occurring every 2-3 months. Laboratory findings confirmed high HSV-1 IgG titers. Histological examination supported the diagnosis of bullous erythema multiforme. The patient was treated successfully with oral acyclovir suppression therapy, leading to a complete resolution of symptoms with no recurrences for six months.

Conclusion

This case highlights the importance of recognizing HSV as a potential trigger for recurrent bullous erythema multiforme and the effectiveness of antiviral suppression therapy in preventing recurrences.

Recommendation

Early identification of recurrent HSV-associated erythema multiforme is crucial for timely intervention. Long-term suppressive antiviral therapy should be considered in patients with frequent recurrences.

References

Trayes KP, Love G, Studdiford JSJAfp. Erythema multiforme: recognition and management. 2019;100(2):82-8.

Zaouak A, Daldoul M, Chamli A, Frioui R, Khanchel F, Brahim EB, et al. Cefixime‐induced bullous erythema multiforme major. 2022;61(8):e280-e2. https://doi.org/10.1111/ijd.16119

Rock N, Belli D, Bajwa NJTJop. Erythema bullous multiforme: a complication of Mycoplasma pneumoniae infection. 2014;164(2):421. https://doi.org/10.1016/j.jpeds.2013.10.014 PMid:24252790

Schalock PC, Brennick JB, Dinulos JGJJotAAoD. Mycoplasma pneumoniae infection associated with bullous erythema multiforme. 2005;52(4):705-6. https://doi.org/10.1016/j.jaad.2004.11.074 PMid:15793531

Chen Y-C, Chang C-HJ中. Herpes simplex virus-associated recurrent erythema multiforme: the implication of mhc class molecules on susceptibility. 2008;26(3):165-70.

Douglas JM, Critchlow C, Benedetti J, Mertz GJ, Connor JD, Hintz MA, et al. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. 1984;310(24):1551-6. https://doi.org/10.1056/NEJM198406143102402 PMid:6328298

Moomaw MD, Cornea P, Rathbun RC, Wendel KAJEroa-it. Review of antiviral therapy for herpes labialis, genital herpes and herpes zoster. 2003;1(2):283-95. https://doi.org/10.1586/14787210.1.2.283 PMid:15482124